The abstracts are grouped under subject chapters such as characteristics of opiate use, treatment, relationship with crime, etc., and each abstract is full and in a standard format. Perhaps the most valuable feature is a condensation of the findings into several factual kernels with very extensive cross-indexing.
Clearly it is an important work for those carrying out research into psychosocial aspects of drug use and abuse. For a medical audience it has the usual dominance of special terminology: 'but it is possible that more salient and unmeasured (or unmeasurable) factors such as dispositional or motivational variables may account for the difference'.
Many will be impressed by this computerized production, which will clearly grow as a method for encapsulating information. It should be stressed that the work only covers drugs which, by societal definition, are abused. However, within the selections and limitations given above, the drug coverage is comprehensive, from alcohol through opiates to tranquillizers. The effect of glucose on neuronal activity, glucose transfer across the blood-brain barrier, ONS regulation of insulin, and glucagon secretion, insulin binding to brain and brain microvessels, innervation of the liver, the role of COK-like peptides and insulin in appetite regulation and conditioned hypoglycaemia are the subjects of competently prepared and interesting chapters in this book. Appropriately, the book begins with a scholarly chapter on the modern anatomy of the hypothalamus. The book also contains four chapters which, although they have little or nothing to do with the CNS regulation of carbohydrate metabolism, are worth reading. Two of these are written by Martin Reivich, Joel Greenberg and Abass Alavi on the measurement of local cerebral glucose metabolism in animals by ['SC] and [3H]-2-deoxyglucose autoradiography and in man by positron emission tomography. The other two chapters, by Jesse Roth and associates and Rosalyn Yalow and John Eng, continue the fascinating and heated debate between these two groups of workers on whether, as Roth asserts, insulin is synthesized in brain and other extrapancreatic tissues in vertebrates and invertebrates (including bacteria). Roth finds it necessary to add a 13 page appendix dealing with Yalow's criticisms of his findings of expancreatic synthesis of insulin. However, as Jesse Roth must know, proof of his hypothesis requires the demonstration of the presence and expression of the insulin gene in extrapancreatic tissue. Although the book would have benefited from a more focused, discriminating and analytical account of the control of insulin and glucagon secretion by neuropeptides (there are two chapters on this subject, almost identical in style and content, which catalogue the effects of neuropeptides) and an updated review of carbohydrate metabolism to show precisely where and how neural control fits into the scheme, Andrew Szabo has succeeded in producing a volume which both physiologists and physicians might wish to have in their library. G It seems unlikely that, in -the modern climate of opinion towards medical research and the cost effectiveness of the physician's time, two investigators will ever again be able to give a lifetime's work to 'Investigating diseases no one's got". It is tempting to criticize such a field of endeavour as 'a happy adventure playground for your friendly neighbourhood research worker'. However, it is a fact that the work initiated by Dr Scheinberg in his studies of caeruloplasmin and its relation to disordered copper metabolism, way back in the early 1950s, has borne fruit in a complete rethinking ofthe pathogenesis of Wilson's disease. It has also resulted in a revolution in its management by the interest sparked off worldwide in this not so rare inborn error of metabolism. Drs Scheinberg and Sternlieb here summarize 30 years of research and clinical experience in a most useful monograph which should be on the shelf of every practising paediatrician, hepatologist and neurologist. If, as seems probable, the incidence of Wilson's disease is indeed 29 per million, then there must be something like 1500 cases in the United Kingdom, probably less than half of whom have been diagnosed. Let Us hope, that this book will help to find some of these missing cases.
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